氯胺酮、芬太尼、舒芬太尼、新斯的明、右美托咪定、咪达唑仑、卓哌啶等鞘内佐剂术后镇痛特点及其对脊髓麻醉的影响

A. Yektaş
{"title":"氯胺酮、芬太尼、舒芬太尼、新斯的明、右美托咪定、咪达唑仑、卓哌啶等鞘内佐剂术后镇痛特点及其对脊髓麻醉的影响","authors":"A. Yektaş","doi":"10.21767/2386-5180.100288","DOIUrl":null,"url":null,"abstract":"Aim: This study was designed to compare the intraoperative, postoperative analgesic characteristics and adverse effects of intrathecal combinations of several adjuvant agents combined with hyperbaric bupivacaine in the cases who underwent spinal anaesthesia. Materials and methods: 180 cases were randomized to 9 groups of 20 cases (n=20). 15 mg of 0.5% hyperbaric bupivacaine and 0.5 ml of serum physiological were administrated to the control group (group-0). In the other groups, instead of serum physiological: Group-1 (2.5 mg hyperbaric bupivacaine), Group-2 (12.5 mg ketamine), Group-3 (25 μgr Fentanyl), Group-4 (2.5 μg sufentanyl), Group-5 (2 μg dexmedetomidine), Group-6 (250 μg neostigmine), Group-7 (500 μg midazolame), Group-8 (1.25 mg Droperidole) were combined with hyperbaric bupivacaine. Total spinal drug volume was 3.5 ml. Intraoperative and postoperative side effects, time to the first pain, and the characteristics of spinal anaesthesia were recorded. Results: Intrathecal adjuvant agents had no effects on the characteristics of the spinal anaesthesia (p>0.05). Time to the first pain was similar between the groups (p>0.05). The most common side effect was pruritus in Group-3 and Group-4 (p>0.05), nausea-vomiting in Group-6 (p>0.05), urinary retention in Group-2 and Group-4 (p>0.05), and PSBA in Group-1 and Group-3 (p>0.05). Discussion: No differences in the time to the first pain were found between intrathecal adjuvant agents. Their effects on the characteristics of spinal anaesthesia were similar. Each adjuvant agent causes specific side effects. However, postoperative analgesic requirement was not considered in our study, and dose-finding studies (which are performed to determine the adjuvant agent doses that cause minimal and maximal side effects) were not performed. Further studies should be performed to evaluate those factors.","PeriodicalId":8195,"journal":{"name":"Annals of Clinical and Laboratory Research","volume":"2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Post-operative Analgesic Characteristics of Intrathecal Adjuvant AgentsIncluding Ketamine, Fentanyl, Sufentanyl, Neostigmine, Dexmedetomidine, Midazolame and Droperidole and their Effects on Spinal Anesthesia\",\"authors\":\"A. Yektaş\",\"doi\":\"10.21767/2386-5180.100288\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: This study was designed to compare the intraoperative, postoperative analgesic characteristics and adverse effects of intrathecal combinations of several adjuvant agents combined with hyperbaric bupivacaine in the cases who underwent spinal anaesthesia. Materials and methods: 180 cases were randomized to 9 groups of 20 cases (n=20). 15 mg of 0.5% hyperbaric bupivacaine and 0.5 ml of serum physiological were administrated to the control group (group-0). In the other groups, instead of serum physiological: Group-1 (2.5 mg hyperbaric bupivacaine), Group-2 (12.5 mg ketamine), Group-3 (25 μgr Fentanyl), Group-4 (2.5 μg sufentanyl), Group-5 (2 μg dexmedetomidine), Group-6 (250 μg neostigmine), Group-7 (500 μg midazolame), Group-8 (1.25 mg Droperidole) were combined with hyperbaric bupivacaine. Total spinal drug volume was 3.5 ml. Intraoperative and postoperative side effects, time to the first pain, and the characteristics of spinal anaesthesia were recorded. Results: Intrathecal adjuvant agents had no effects on the characteristics of the spinal anaesthesia (p>0.05). Time to the first pain was similar between the groups (p>0.05). The most common side effect was pruritus in Group-3 and Group-4 (p>0.05), nausea-vomiting in Group-6 (p>0.05), urinary retention in Group-2 and Group-4 (p>0.05), and PSBA in Group-1 and Group-3 (p>0.05). Discussion: No differences in the time to the first pain were found between intrathecal adjuvant agents. Their effects on the characteristics of spinal anaesthesia were similar. Each adjuvant agent causes specific side effects. However, postoperative analgesic requirement was not considered in our study, and dose-finding studies (which are performed to determine the adjuvant agent doses that cause minimal and maximal side effects) were not performed. Further studies should be performed to evaluate those factors.\",\"PeriodicalId\":8195,\"journal\":{\"name\":\"Annals of Clinical and Laboratory Research\",\"volume\":\"2 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Clinical and Laboratory Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21767/2386-5180.100288\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Clinical and Laboratory Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21767/2386-5180.100288","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

摘要

目的:本研究旨在比较脊髓麻醉患者鞘内联合几种佐剂联合高压布比卡因的术中、术后镇痛特点及不良反应。材料与方法:180例患者随机分为9组,每组20例(n=20)。对照组(0组)给予0.5%高压布比卡因15 mg,血清生理盐水0.5 ml。其他组以血清生理替代:1组(高压布比卡因2.5 mg)、2组(氯胺酮12.5 mg)、3组(芬太尼25 μg)、4组(舒芬太尼2.5 μg)、5组(右美托咪定2 μg)、6组(新斯的明250 μg)、7组(咪达唑胺500 μg)、8组(卓哌啶1.25 mg)联合使用高压布比卡因。脊髓药物总容量为3.5 ml。记录术中、术后不良反应、首次疼痛时间及脊髓麻醉特点。结果:鞘内佐剂对脊髓麻醉特征无影响(p < 0.05)。两组间首次疼痛时间差异无统计学意义(p < 0.05)。最常见的不良反应为3、4组瘙痒(p>0.05)、6组恶心呕吐(p>0.05)、2、4组尿潴留(p>0.05)、1、3组PSBA (p>0.05)。讨论:鞘内佐剂在首次疼痛的时间上没有差异。它们对脊髓麻醉特征的影响相似。每种佐剂都会产生特定的副作用。然而,我们的研究没有考虑术后镇痛需求,也没有进行剂量发现研究(用于确定引起最小和最大副作用的佐剂剂量)。应该进行进一步的研究来评价这些因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Post-operative Analgesic Characteristics of Intrathecal Adjuvant AgentsIncluding Ketamine, Fentanyl, Sufentanyl, Neostigmine, Dexmedetomidine, Midazolame and Droperidole and their Effects on Spinal Anesthesia
Aim: This study was designed to compare the intraoperative, postoperative analgesic characteristics and adverse effects of intrathecal combinations of several adjuvant agents combined with hyperbaric bupivacaine in the cases who underwent spinal anaesthesia. Materials and methods: 180 cases were randomized to 9 groups of 20 cases (n=20). 15 mg of 0.5% hyperbaric bupivacaine and 0.5 ml of serum physiological were administrated to the control group (group-0). In the other groups, instead of serum physiological: Group-1 (2.5 mg hyperbaric bupivacaine), Group-2 (12.5 mg ketamine), Group-3 (25 μgr Fentanyl), Group-4 (2.5 μg sufentanyl), Group-5 (2 μg dexmedetomidine), Group-6 (250 μg neostigmine), Group-7 (500 μg midazolame), Group-8 (1.25 mg Droperidole) were combined with hyperbaric bupivacaine. Total spinal drug volume was 3.5 ml. Intraoperative and postoperative side effects, time to the first pain, and the characteristics of spinal anaesthesia were recorded. Results: Intrathecal adjuvant agents had no effects on the characteristics of the spinal anaesthesia (p>0.05). Time to the first pain was similar between the groups (p>0.05). The most common side effect was pruritus in Group-3 and Group-4 (p>0.05), nausea-vomiting in Group-6 (p>0.05), urinary retention in Group-2 and Group-4 (p>0.05), and PSBA in Group-1 and Group-3 (p>0.05). Discussion: No differences in the time to the first pain were found between intrathecal adjuvant agents. Their effects on the characteristics of spinal anaesthesia were similar. Each adjuvant agent causes specific side effects. However, postoperative analgesic requirement was not considered in our study, and dose-finding studies (which are performed to determine the adjuvant agent doses that cause minimal and maximal side effects) were not performed. Further studies should be performed to evaluate those factors.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信